Table 2.
Group | Dose (mg/kg) | Con A (5 μg/mL) | LPS (10 μg/mL) |
---|---|---|---|
IL-2 (pg/mL) | |||
NC | – | 221.44 ± 56.47 | 53.37 ± 9.86 |
LAC | 198 | 293.43 ± 67.66* | 86.92 ± 17.35* |
LAC | 593 | 291.99 ± 61.01* | 85.73 ± 15.81* |
LAC | 988 | 307.87 ± 45.74* | 86.35 ± 23.85* |
PC | 260 | 262.87 ± 51.48 | 69.70 ± 21.97 |
IL-4 (pg/mL) | |||
NC | – | 21.25 ± 9.80 | 4.92 ± 1.34 |
LAC | 198 | 21.28 ± 7.19 | 7.28 ± 3.36 |
LAC | 593 | 19.10 ± 5.90 | 7.25 ± 3.70 |
LAC | 988 | 17.72 ± 4.30 | 7.53 ± 2.89 |
PC | 260 | 14.86 ± 7.50 | 5.09 ± 1.80 |
TNF-α (pg/mL) | |||
NC | – | 313.93 ± 107.64 | 221.79 ± 90.35 |
LAC | 198 | 410.36 ± 82.17* | 331.79 ± 125.30 |
LAC | 593 | 410.24 ± 106.57* | 433.81 ± 176.07* |
LAC | 988 | 417.19 ± 77.95* | 410.00 ± 138.37* |
PC | 260 | 442.19 ± 90.03* | 293.08 ± 77.07 |
IFN-γ (pg/mL) | |||
NC | – | 1329.82 ± 345.51 | 186.23 ± 58.04 |
LAC | 198 | 1698.73 ± 323.08* | 204.77 ± 67.81 |
LAC | 593 | 1690.90 ± 360.44* | 276.86 ± 97.37* |
LAC | 988 | 1765.42 ± 207.41* | 270.92 ± 109.60* |
PC | 260 | 1737.08 ± 210.89* | 199.36 ± 76.81 |
GM-CSF (pg/mL) | |||
NC | – | 226.52 ± 62.19 | 21.04 ± 4.13 |
LAC | 198 | 290.70 ± 42.21* | 25.33 ± 6.32 |
LAC | 593 | 317.65 ± 95.27* | 31.47 ± 7.95* |
LAC | 988 | 316.36 ± 68.19* | 29.57 ± 9.55* |
PC | 260 | 214.17 ± 70.38 | 21.96 ± 7.85 |
All data were presented as mean ± SD.
NC: normal control; PC: positive control.
LAC: solid-state cultivated powder of T. camphoratus.
*p < 0.05 compared to normal control.